7. Results of network meta‐analysis for outcome skeletal‐related events: bone radiotherapy. Prediction intervals. Treatments are ordered by P‐score (descending).
95% prediction intervals (risk ratios, random‐effects model) | ||||
Denosumab | [ 0.85, 1.54 ] | [ 0.6, 3.31 ] | [ 0.76, 2.55 ] | [ 0.86, 2.38 ] |
[ 0.65, 1.17 ] | Zoledronic acid | [ 0.55, 2.74 ] | [ 0.72, 2.07 ] | [ 0.83, 1.89 ] |
[ 0.3, 1.67 ] | [ 0.37, 1.81 ] | Pamidronate | [ 0.46, 2.14 ] | [ 0.51, 2.03 ] |
[ 0.39, 1.31 ] | [ 0.48, 1.39 ] | [ 0.47, 2.18 ] | Clodronate | [ 0.72, 1.46 ] |
[ 0.42, 1.16 ] | [ 0.53, 1.21 ] | [ 0.49, 1.95 ] | [ 0.69, 1.38 ] | No treatment/placebo |